[go: up one dir, main page]

IS8014A - Blöndur sem innihalda imídasópýridín og notkun þeirra í meðhöndlun maga- og garnabólgusjúkdóma - Google Patents

Blöndur sem innihalda imídasópýridín og notkun þeirra í meðhöndlun maga- og garnabólgusjúkdóma

Info

Publication number
IS8014A
IS8014A IS8014A IS8014A IS8014A IS 8014 A IS8014 A IS 8014A IS 8014 A IS8014 A IS 8014A IS 8014 A IS8014 A IS 8014A IS 8014 A IS8014 A IS 8014A
Authority
IS
Iceland
Prior art keywords
treatment
gastrointestinal disorders
preparations containing
imidazopyridine
containing imidazopyridine
Prior art date
Application number
IS8014A
Other languages
English (en)
Inventor
Buhr Wilm
Jan Zimmermann Peter
Palmer Andreas
Brehm Christof
Klein Thomas
Senn-Bilfinger Jörg
Simon Wolfgang-Alexander
Postius Stefan
Vittoria Chiesa M.
Kromer Wolfgang
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IS8014A publication Critical patent/IS8014A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8014A 2003-02-17 2005-09-08 Blöndur sem innihalda imídasópýridín og notkun þeirra í meðhöndlun maga- og garnabólgusjúkdóma IS8014A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003530 2003-02-17
PCT/EP2004/050138 WO2004071391A2 (en) 2003-02-17 2004-02-16 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders

Publications (1)

Publication Number Publication Date
IS8014A true IS8014A (is) 2005-09-08

Family

ID=32864938

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8014A IS8014A (is) 2003-02-17 2005-09-08 Blöndur sem innihalda imídasópýridín og notkun þeirra í meðhöndlun maga- og garnabólgusjúkdóma

Country Status (18)

Country Link
US (1) US20060154954A1 (is)
EP (1) EP1599175A2 (is)
JP (1) JP2006517952A (is)
KR (1) KR20050100671A (is)
CN (1) CN1747731A (is)
AR (1) AR044497A1 (is)
AU (1) AU2004212337A1 (is)
BR (1) BRPI0407541A (is)
CA (1) CA2515676A1 (is)
HR (1) HRP20050790A2 (is)
IS (1) IS8014A (is)
MX (1) MXPA05008490A (is)
NO (1) NO20054160L (is)
PL (1) PL377581A1 (is)
RS (1) RS20050603A (is)
TW (1) TW200418467A (is)
WO (1) WO2004071391A2 (is)
ZA (1) ZA200505451B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006117316A1 (en) * 2005-04-29 2006-11-09 Nycomed Gmbh Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
EP1879891A1 (en) * 2005-04-29 2008-01-23 Nycomed GmbH Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
EA005377B1 (ru) * 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ
JP2002528548A (ja) * 1998-11-03 2002-09-03 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング イミダゾナフチリジン
ES2199810T3 (es) * 1999-04-17 2004-03-01 Altana Pharma Ag Haloalcoxi-imidazonaftiridinas.
JP2003528876A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト アルキル化されたイミダゾピリジン誘導体
AU784611B2 (en) * 2000-03-29 2006-05-11 Altana Pharma Ag Pyrano(2,3-C)imidazo(-1,2-A)pyridine derivatives for the treatment of gastrointestinal disorders
IL151198A0 (en) * 2000-03-29 2003-04-10 Altana Pharma Ag Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
MXPA02009551A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
US20040082605A1 (en) * 2001-03-08 2004-04-29 Arne Eek Use
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines

Also Published As

Publication number Publication date
MXPA05008490A (es) 2005-10-18
NO20054160L (no) 2005-11-14
EP1599175A2 (en) 2005-11-30
AU2004212337A1 (en) 2004-08-26
RS20050603A (sr) 2007-09-21
US20060154954A1 (en) 2006-07-13
WO2004071391A2 (en) 2004-08-26
AR044497A1 (es) 2005-09-14
BRPI0407541A (pt) 2006-02-14
KR20050100671A (ko) 2005-10-19
ZA200505451B (en) 2006-08-30
WO2004071391A3 (en) 2005-05-12
NO20054160D0 (no) 2005-09-07
CA2515676A1 (en) 2004-08-26
PL377581A1 (pl) 2006-02-06
HRP20050790A2 (en) 2006-12-31
CN1747731A (zh) 2006-03-15
JP2006517952A (ja) 2006-08-03
TW200418467A (en) 2004-10-01

Similar Documents

Publication Publication Date Title
IS8127A (is) Aðferðir og samsetningar sem nýta ónæmistemprandiefnasambönd í meðferð og umönnun á krabba og öðrum sjúkdómum
SI1599467T1 (sl) Novi cianopiridinski derivati uporabni pri zdravljenju raka in drugih motenj
EP1644021A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
IS8349A (is) 2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
EP1691729A4 (en) ENCAPSULATION DEVICE AND METHODS OF USE
TWI349551B (en) Thiophenepyrimidinone derivatives and their use in therapy
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
ZA200606203B (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
IL169153A0 (en) Formulation and methods for the treatment of thrombocythemia
LT2340872T (lt) Naujos farmacinės kompozicijos, naudingos nemigos gydyme
IS6870A (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og notkun þeirra í meðferð
SG110107A1 (en) Compound and use in treatment
IS8014A (is) Blöndur sem innihalda imídasópýridín og notkun þeirra í meðhöndlun maga- og garnabólgusjúkdóma
TWI365187B (en) 7-azaindoles and the use thereof as therapeutic agents
IS8390A (is) Notkun á gaboxadóli við meðhöndlun á svefnleysi
AU2003271016A1 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
IS6660A (is) Ný bispídínefnasambönd og notkun þeirra í meðhöndlun á hjartsláttarglöpum
GB0612186D0 (en) Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatment
HUP0600114A2 (en) Benzofuran derivatives and their use in the treatment of microbal infections
AU2003247094A8 (en) Enhancing the effect of radioimmunotherapy in the treatment of tumors